BiotechTube

Emtricitabine

ApprovedUNKNOWN
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Hepatitis B, Chronic

Conditions

Hepatitis B, Chronic

Trial Timeline

Dec 1, 2014 → Dec 1, 2017

NCT ID
NCT02327663

About Emtricitabine

Emtricitabine is a approved stage product being developed by Pacific Biosciences for Hepatitis B, Chronic. The current trial status is unknown. This product is registered under clinical trial identifier NCT02327663. Target conditions include Hepatitis B, Chronic.

Hype Score Breakdown

Clinical
30
Activity
20
Company
2
Novelty
10
Community
12

Clinical Trials (4)

NCT IDPhaseStatus
NCT02327676ApprovedUNKNOWN
NCT02327702ApprovedUNKNOWN
NCT02327715ApprovedUNKNOWN
NCT02327663ApprovedUNKNOWN

Competing Products

20 competing products in Hepatitis B, Chronic

See all competitors
ProductCompanyStageHype Score
VK2809 + PlacebosViking TherapeuticsPhase 2
47
TERN-501 + TERN-101Terns PharmaceuticalsPhase 2
49
TERN-101Terns PharmaceuticalsPhase 2
49
TERN-201Terns PharmaceuticalsPhase 1
30
IVA337 + IVA337 + PlaceboInventivaPhase 2
47
IVA337 + Placebo + EmpagliflozinInventivaPhase 2
47
IVA337 + PlaceboInventivaPhase 3
72
Pegasys® + Pegasys®Chugai PharmaceuticalApproved
85
peginterferon alfa-2a + rivavirinChugai PharmaceuticalPhase 3
77
SOF + COPEChugai PharmaceuticalPre-clinical
23
Colesevelam HclDaiichi SankyoPhase 2
52
ASP9831 + PlaceboAstellas PharmaPhase 2
52
FK788Astellas PharmaPhase 2
52
MK-2248MerckPhase 1
33
Interferon alfacon-1Astellas PharmaPhase 3
77
Pegylated Interferon + RibavirinAstellas PharmaApproved
85
Tacrolimus + steroids, monoclonal anti-IL2R antibodyAstellas PharmaPhase 2
52
Dolutegravir + Rlipivirine + GSK1265744ShionogiPhase 1
33
Dolutegravir + MethadoneShionogiPhase 1
33
Clevudine + AdefovirEisaiPhase 3
77

Other Products from Pacific Biosciences

pantoprazole + bismuth + metronidazole + tetracyclineApproved
77
A single oral 5 mg of duterium labeled methamphetamineApproved
77
RamiprilApproved
77
Emtricitabine plus adefovir dipivoxilApproved
77
Zolpidem + TrazodoneApproved
77